Freestone Grove Partners’s Amrize Ltd AMRZ Stock Holding History

Freestone Grove Partners’s Portfolio AMRZ Stock Details AMRZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,205,796	Closed	-$65.2M	–	1221
2025 Q4	$65.2M	Buy	+1,205,796	New	+$61.5M	0.47%	48

Other funds holding AMRZ

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Zurich Cantonal Bank Zurich, Switzerland $52.2B AUM 40.82% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Freestone Grove Partners's AMRZ Position: Q1 2026 in Review

Freestone Grove Partners sold out of Amrize Ltd (AMRZ) in Q1 2026, closing a stake of 1,205,796 shares — an estimated $65.2M sold.

Freestone Grove Partners first reported a position in AMRZ in Q4 2025 and held it in 1 quarter. The position peaked at $65.2M in Q4 2025. 449 funds tracked by Wall St. Rank hold AMRZ as of Q1 2026.

Freestone Grove Partners reported no remaining Amrize Ltd position as of Q1 2026 after selling out during the quarter.
Freestone Grove Partners sold 1,205,796 Amrize Ltd shares in Q1 2026, an estimated $65.2M.
Freestone Grove Partners first reported a position in Amrize Ltd in Q4 2025 and held it in 1 quarter.
Freestone Grove Partners's Amrize Ltd position peaked at $65.2M in Q4 2025.
449 funds tracked by Wall St. Rank held Amrize Ltd as of Q1 2026.

Based on Freestone Grove Partners's 13F filing for Q1 2026, filed 15 May 2026.